Skip to main content

Circulating DNA and DNase activity in human blood.

Tamkovich SN, Cherepanova AV, Kolesnikova EV, Rykova EY, Pyshnyi DV, Vlassov VV, Laktionov PP

Publication: Ann N Y Acad Sci (2006) • Vol 1075 • Page 191-6PMID: 17108211View on PubMed

Purpose

This paper investigated the effect of cancer diagnosis and patient gender on circulating DNA levels and DNAse activity.

Conclusion

The average circulating DNA levels were approximately 10-fold higher in patients with cancer than healthy controls and the DNase activity in plasma was below the limit of detection (<0.08 units/mL) from cancer patients but averaged 0.356 units/mL from healthy patients. The authors postulate that the decreased DNase activity in plasma from cancer patients may be responsible for the higher levels of circulating DNA observed.  The average circulating DNA levels were higher in healthy men than women but the average DNAse activity was not significantly different.

Studies (1)

Purpose

This study compared circulating DNA levels and DNAse activity in patients with stomach or colon cancer with those in healthy individuals and investigated the effects of patient gender. Blood was collected from nine patients with colon cancer, nine patients with stomach cancer, and 20 healthy individuals (10 males and 10 females) into tubes containing EDTA and phosphate-buffered saline and immediately stored at 4˚C. Within 4 h, plasma was obtained by double centrifugation at 400 x g for 10 min at 4˚C and was subsequently stored at -20˚C. DNA was isolated using a glass-milk-based method and quantified by flouremetry.  DNAse activity was determined by measuring the loss of fluorescently-labeled double-stranded DNA. EDTA was neutralized by addition of magnesium chloride.

Summary of Findings

The average circulating DNA levels were approximately 10-fold higher in patients with cancer than healthy controls and were higher in patients with stomach cancer than those with colon cancer (427 ng/mL versus 350 ng/mL, significance not determined). Interestingly, the DNase activity was below the limit of detection (<0.08 units/mL) in plasma from cancer patients but averaged 0.356 units/mL in the plasma from healthy patients. Further, 5 µL of plasma from a cancer patient was able to completely inhibit the activity of 0.005 units of DNase. The authors postulate that the decreased DNase activity in plasma from cancer patients may be responsible for the higher levels of circulating DNA observed.

The average circulating DNA levels were higher in healthy men than women (41 ng/mL versus 21 ng/mL significance not determined), but the average DNase activity was not significantly different (0.307 units/mL versus 0.405 units/mL, respectively).

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    NeoplasticCarcinoma
    Normal
  • Platforms

    DNAFluorometry
    ProteinEnzyme assay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Colon cancer
    Healthy
    Stomach cancer
    PreaquisitionPatient gender
    Female
    Male